EU Commission/EIB launch financing tool dedicated to R&D in infectious diseases

2015 07 14 Written by Vaccines Europe

Vaccines Europe welcomes the new financing tool dedicated specifically to R&D in infectious diseases that has been launched by the European Commission and the European Investment Bank.

This new instrument, InnovFin Infectious Diseases, was  established within the InnovFin – EU Finance for Innovators family of instruments and will provide loans to high-risk projects in the area of infectious disease R&D and reinvigorate and attract co-investment from other investors by incentivising R&D activities for an uncertain market. It can be accessed by small, medium and large companies, research infrastructures, universities, non-profit organisations, and Special Purpose Vehicles (SPV) established and operating in one or several of the EU Member States and Associated Countries.

Please find a summary factsheet provided under this link: http://www.eib.org/attachments/documents/innovfin_infectious_diseases_flysheet_en.pdf

A first loan under this new facility was signed just recently:  http://ec.europa.eu/research/index.cfm?pg=newsalert&year=2015&na=na-130715

Queries regarding this facility can be directed to: innovfinIDFF@eib.org